These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 38314300)

  • 1. Mesenchymal stromal cells in myeloid malignancies: Immunotherapeutic opportunities.
    Vukotić M; Kapor S; Simon F; Cokic V; Santibanez JF
    Heliyon; 2024 Feb; 10(3):e25081. PubMed ID: 38314300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies.
    Kapor S; Santibanez JF
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy.
    Kapor S; Radojković M; Santibanez JF
    Acta Histochem; 2024 Oct; 126(5-7):152183. PubMed ID: 39029317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
    Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
    Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
    Sorokina T; Shipounova I; Bigildeev A; Petinati N; Drize N; Turkina A; Chelysheva E; Shukhov O; Kuzmina L; Parovichnikova E; Savchenko V
    Eur J Haematol; 2016 Sep; 97(3):245-52. PubMed ID: 26643284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome Activation in Myeloid Malignancies-Friend or Foe?
    Andina N; Bonadies N; Allam R
    Front Cell Dev Biol; 2021; 9():825611. PubMed ID: 35155452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation by ASXL1 in myeloid malignancies.
    Yang FC; Agosto-Peña J
    Int J Hematol; 2023 Jun; 117(6):791-806. PubMed ID: 37062051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells in myeloid malignancies.
    Schroeder T; Geyh S; Germing U; Haas R
    Blood Res; 2016 Dec; 51(4):225-232. PubMed ID: 28090484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
    Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
    Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Azuma K; Umezu T; Imanishi S; Asano M; Yoshizawa S; Katagiri S; Ohyashiki K; Ohyashiki JH
    Leuk Res; 2017 Nov; 62():23-28. PubMed ID: 28964959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of innate immune signaling and inflammation in the pathogenesis of myeloid malignancies].
    Muto T
    Rinsho Ketsueki; 2023; 64(9):962-969. PubMed ID: 37793872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia.
    Ciciarello M; Corradi G; Loscocco F; Visani G; Monaco F; Cavo M; Curti A; Isidori A
    Front Oncol; 2019; 9():1135. PubMed ID: 31709192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies.
    Behrmann L; Wellbrock J; Fiedler W
    Expert Opin Ther Targets; 2020 May; 24(5):451-462. PubMed ID: 32188313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.